ArticleMalawi medical journal : the journal of Medical Association of Malawi2026
Country readiness in responding to COVID-19 Vaccine-Related Events (VREs) in Malawi.
Article in Malawi medical journal : the journal of Medical Association of Malawi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality and Timeliness of Pharmacovigilance Reporting in Malawi: A Cross-Sectional Analysis of Individual Case Safety Reports.Drug, healthcare and patient safety · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Malawi Ministry of Health (MMoH) and partners developed a comprehensive Coronavirus Disease 2019 (COVID-19) Vaccine Related Events (VREs) response plan in 2022. A VRE is any anticipated threat that could erode the public's trust in vaccines or vaccination delivery. We explored the MMoH's readiness to implement the plan by assessing the availability of VRE-related documents describing the overall process of identifying, reporting, investigating, and coordinating a VRE response; and by assessing the strengths and weaknesses of the current system. Methods: We conducted a cross-sectional assessment among MMoH staff involved in VRE response at national, district, and health facility level using a survey and a semi-structured interview guide in ten districts in Malawi in 2023. Ten VRE-related documents were assessed and their availability visually confirmed. We assessed each of the survey findings by district and zone. Ten key themes pertaining to VRE identification, reporting, investigation, and response were explored in 109 Key Informant Interviews (KIIs) and six Focus Group Discussions (FGDs). Results: More than 60% of respondents reported having access to VRE-related documentation, but less than 10% reported access to non-Adverse Events Following Immunisation (non-AEFIs)-related guidance. Participants identified existing processes for AEFIs, but noted the lack of training, coordination, and budgetary support for both AEFI and non-AEFI activities. Health facilities with VRE response teams or committees had implemented aspects of the response plan, emphasizing the need to formulate teams or committees in all health facilities. Conclusion: Adequate implementation of Malawi's VRE response plan will require expanded training opportunities, sustained funding, and improved coordination across all levels of the health system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.